Related Experiment Video
Updated: Jun 17, 2025

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Poor Patient-Reported Outcomes and Impaired Work Productivity in Patients With Inflammatory Bowel Disease in
Raymond K Cross1, Jenny S Sauk2, Joe Zhuo3
1Division of Gastroenterology and Hepatology, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
Inflammatory bowel disease (IBD) patients experience significant work productivity loss and impaired psychosocial function, even during remission. This highlights an unmet need for better management strategies in Crohn's disease (CD) and ulcerative colitis (UC) patients.
Area of Science:
- Gastroenterology
- Clinical Research
- Health Outcomes
Background:
- Inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), significantly impacts patients' quality of life.
- Understanding the relationship between disease severity, patient-reported outcomes (PROs), and work productivity is crucial for comprehensive IBD management.
Purpose of the Study:
- To evaluate the associations between IBD disease severity and patient-reported outcomes.
- To assess the impact of IBD on work productivity and daily activity impairment.
- To identify unmet needs in IBD patient care regarding psychosocial function and work capacity.
Main Methods:
- A real-world analysis of 1543 IBD patients (812 CD, 731 UC) from the CorEvitas IBD Registry (May 2017-September 2019).
- Disease severity assessed using the Harvey-Bradshaw Index (CD) and partial Mayo Score (UC).
- Psychosocial PROs (PROMIS) and work productivity (WPAI) were evaluated using regression analyses.
Main Results:
- A significant proportion of IBD patients, including those in remission, reported impaired psychosocial function (e.g., fatigue, depression) and reduced work productivity.
- For CD patients in remission, 54.3% reported work productivity loss and 57.1% activity impairment.
- For UC patients in remission, 43.5% reported activity impairment, and scores for psychosocial outcomes and work productivity worsened with increasing disease severity.
Conclusions:
- IBD patients, irrespective of disease activity level, experience substantial impairment in psychosocial well-being and work productivity.
- Even patients in remission demonstrate significant deficits, underscoring an unmet need for improved therapeutic and supportive strategies.
- These findings emphasize the systemic impact of IBD beyond gastrointestinal symptoms, necessitating a holistic approach to patient care.
More Related Videos
07:38Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing
Published on: September 13, 2016
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents